Clinical Trial Update: NI-0401 in Patients With Acute Renal Allograft Rejection [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on the NI-0401 trial in patients with acute renal allograft rejection, spanning Phase 1 and Phase 2; the study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Allograft Rejection

Drugs mentioned

• NI-0401

Snippet

Sponsor: Light Chain Bioscience - Novimmune SA | Conditions: Acute Renal Transplant Rejection | Phase 1, Phase 2 | Status: COMPLETED